Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6. [electronic resource] by
- Lu, Kang
- Fang, Xiao-sheng
- Feng, Li-li
- Jiang, Yu-jie
- Zhou, Xiang-xiang
- Liu, Xin
- Li, Pei-pei
- Chen, Na
- Ding, Mei
- Wang, Na
- Zhang, Jie
- Wang, Xin
Producer: 20150420
In:
Cancer letters vol. 359
Availability: No items available.
|
|
8.
|
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial. [electronic resource] by
- Cai, Ming-Ci
- Cheng, Shu
- Wang, Xin
- Hu, Jian-Da
- Song, Yong-Ping
- Huang, Yao-Hui
- Yan, Zi-Xun
- Jiang, Yu-Jie
- Fang, Xiao-Sheng
- Zheng, Xiao-Yun
- Dong, Li-Hua
- Ji, Meng-Meng
- Wang, Li
- Xu, Peng-Peng
- Zhao, Wei-Li
Producer: 20210513
In:
Genome medicine vol. 12
Availability: No items available.
|